Assessment of sarcopenia as predictor of response and outcome after neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC).

被引：2
|
作者：
Grivas, Petros
Zargar, Homi
Ercole, Cesar Emilio
Kovac, Evan
Remer, Erick M.
Karim, Wadih
Emamekhoo, Hamid
Stephenson, Andrew J.
Fergany, Amr Farouk
Gong, Michael C.
Campbell, Steven C.
Berglund, Ryan Kent
Dreicer, Robert
Rini, Brian I.
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Radiol, Cleveland, OH 44106 USA
[4] Cleveland Clin, Shaker Hts, OH USA
[5] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[6] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15512
引用
收藏
页数：1
相关论文
共 50 条
  • [1] BLADDER-SPARING SURGERY (BSS) FOR MUSCLE-INVASIVE BLADDER CANCER (MIBC) AFTER COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NAC)
    Herr, Harry
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1084 - E1084
  • [2] Optimal timing of radical cystectomy after neoadjuvant chemotherapy in muscle invasive bladder cancer (MIBC)
    Parasramka, Saurabh
    Veedu, Janeesh Sekkath
    Chen, Quan
    Huang, Bin
    Wang, Peng
    Myint, Zin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Lyon, Timothy D.
    Frank, Igor
    Takahashi, Naoki
    Boorjian, Stephen A.
    Moynagh, Michael R.
    Shah, Paras H.
    Tarrell, Robert F.
    Cheville, John C.
    Viers, Boyd R.
    Tollefson, Matthew K.
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 216 - +
  • [4] Frequency and clinical implications of pathologic complete response (pCR) at cystectomy for muscle-invasive bladder cancer (MIBC) with or without neoadjuvant chemotherapy (NAC)
    Galsky, Matt D.
    Stensland, Kristian
    Sfakianos, John
    McBride, Russell Bailey
    Mehrazin, Reza
    Tsao, Che-Kai
    Boffetta, Paolo
    Oh, William K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Alva, Ajjai S.
    Tallman, Christopher T.
    He, Chang
    Hussain, Maha H.
    Hafez, Khaled
    Montie, James E.
    Smith, David C.
    Weizer, Alon Z.
    Wood, David
    Lee, Cheryl T.
    [J]. CANCER, 2012, 118 (01) : 44 - 53
  • [6] Biologic activity of dasatinib administered as neoadjuvant therapy preceding radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC)
    Knudsen, Beatrice
    Hahn, Noah M.
    Daneshmand, Siamak
    Posadas, Edwin M.
    Muhanty, Sambit
    Lerner, Seth P.
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Impact of angiotensin inhibitors on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
    Thomas, Jonathan
    Pond, Gregory Russell
    Curran, Catherine
    Freeman, Dory
    Ravi, Praful
    Mossanen, Matthew
    Preston, Mark A.
    Steele, Graeme S.
    Mantia, Charlene
    McGregor, Bradley Alexander
    Jain, Rakesh K.
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [8] Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC)
    Necchi, Andrea
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    Marandino, Laura
    Bianchi, Marco
    Gallina, Andrea
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Capitanio, Umberto
    Montorsi, Francesco
    Boormans, Joost L.
    Liu, Yang
    de Jong, Joep
    Black, Peter C.
    Dittamore, Ryan
    Davicioni, Elai
    Gibb, Ewan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] ASSOCIATION OF AN IMMUNE-GENE SIGNATURE WITH PATHOLOGIC RESPONSE AND OUTCOME AFTER NEOADJUVANT PEMBROLIZUMAB (PEMBRO), COMPARED TO NEOADJUVANT CHEMOTHERAPY (NAC), IN MUSCLE-INVASIVE BLADDER CANCER (MIBC)
    Necchi, Andrea
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    Marandino, Laura
    Gallina, Andrea
    Bianchi, Marco
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Capitanio, Umberto
    Montorsi, Francesco
    Boormans, Joost
    Liu, Yang
    de Jong, Joep
    Dittamore, Ryan
    Davicioni, Elai
    Black, Peter
    Gibb, Ewan
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E841 - E841
  • [10] Effectiveness of chemotherapy administration and time to cystectomy following neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in the academic and community settings.
    Rose, Tracy Lynn
    Deal, Allison Mary
    Basch, Ethan M.
    Godley, Paul Alphonso
    Rathmell, Kimryn
    Kim, William Y.
    Whang, Young E.
    Dunn, Mary
    Nielsen, Matthew Edward
    Pruthi, Raj
    Wallen, Eric
    Woods, Michael
    Smith, Angela
    Milowsky, Matthew I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345